semaglutide nad+ vs semaglutide Tirzepatide NAD+ Therapy in Conjunction with

Khavinson V, Diomede F, Mironova E, Linkova N, Trofimova S, Trubiani O, Caputi S, Sinjari B

While Merrill sees potential for the future of GLP-1 drugs to be helpful outside treating type 2 diabetes and obesity, he also understands the need for more studies

But I think the little shift was the capacity to exercise

PMID: 231 YardleyDANoguchiSPritchardKIBurrisHABaselgaJGnantMet al

The enhancement of Nrf2 transcription with sulforaphane or melatonin could benefit patients with LONG COVID (Post-Acute Sequelae of SARS-CoV-2 or Post-COVID-Syndrome), a significant proportion (approximately 40%) of individuals with COVID-19 experiencing a variety of symptoms (loss of smell and/or taste, fatigue, cough, aching pain, brain fog, insomnia, shortness of breath, and tachycardia) after 12 weeks (Jarrott et al., 2022

This reframing is a major driver of why GLP-1 medications designed to address insulin resistance have moved into PCOS care